Literature DB >> 10636023

[Diffusion in bone tissue of antibiotics].

E Boselli1, B Allaouchiche.   

Abstract

DIFFICULT ASSESSMENT: Bone and joint infections are difficult to treat. Therapeutic success depends greatly on the diffusion of antibiotics into bone tissue. Few studies have been devoted to this subject and the variable nature of those reported hinders interpretation. Bone biopsies are generally obtained during orthopedic procedures. Antibiotic administration routes vary although intravenous infusion predominates. Agar gel diffusion is generally used for antibiotic assays but methodology varies depending of the study. The most recent reports use high-performance liquid chromatography. DIFFUSION STUDIES: The different studies examining antibiotic diffusion in bone tissue describe three classes: good diffusion (greater than 30%), moderate diffusion (between 15% and 30%), and low diffusion (less than 15%). Antibiotics in the good diffusion class include fluoroquinolones, teicoplanin, macrolides, rifampicin and trimethoprime. Antibiotics with moderate bone diffusion are ureidopenicillins, second and third generation cephalosporins, aminoglycosides, clindamycin, fosfomycin and vancomycin. Those with low bone diffusion are aminopenicillins, penicillin M and first generation cephalosporins. No data is available on the bone diffusion of pristinamycin. DATA
INTERPRETATION: The clinical impact of these classifications must be interpreted with precaution when considering bone and joint infections as they were established on the basis of pharmacokinetic studies and not clinical trials. They would however appear to be useful in guiding antibiotic prophylaxis for orthopedic surgery in protocols with administration conditions and concentration goals similar to the experimental conditions. PRACTICAL ATTITUDES: These laboratory results could be used in clinical practice by comparing the MIC50 of the germs regularly encountered in bone infections (staphylococci, streptococci including enterococci, Gram negative bacilli including P. aeruginosa and H. influenzae) with concentrations obtained in the different studies, i.e. by calculating the inhibitor coefficient (IQ) of each antibiotic for each susceptible germ. This gives a classification by efficacy (excellent IQ > 10, good 1 < IQ < 10, poor IQ < 1) useful for guiding antibiotic choice in the difficult situation of bone and joint infection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10636023

Source DB:  PubMed          Journal:  Presse Med        ISSN: 0755-4982            Impact factor:   1.228


  9 in total

Review 1.  [Perioperative antibiotic prophylaxis. Use in orthopaedics].

Authors:  M Széll; S Hofmann; M Pietsch; E Gerhart; C Wenisch
Journal:  Orthopade       Date:  2006-07       Impact factor: 1.087

Review 2.  Antibiotic Therapy for Prosthetic Joint Infections: An Overview.

Authors:  Benjamin Le Vavasseur; Valérie Zeller
Journal:  Antibiotics (Basel)       Date:  2022-04-05

Review 3.  Ways to Improve Insights into Clindamycin Pharmacology and Pharmacokinetics Tailored to Practice.

Authors:  Laura Armengol Álvarez; Greet Van de Sijpe; Stefanie Desmet; Willem-Jan Metsemakers; Isabel Spriet; Karel Allegaert; Jef Rozenski
Journal:  Antibiotics (Basel)       Date:  2022-05-21

Review 4.  Penetration of antibacterials into bone: pharmacokinetic, pharmacodynamic and bioanalytical considerations.

Authors:  Cornelia B Landersdorfer; Jürgen B Bulitta; Martina Kinzig; Ulrike Holzgrabe; Fritz Sörgel
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

5.  Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.

Authors:  Silvia Garazzino; Alessandro Aprato; Lorena Baietto; Antonio D'Avolio; Agostino Maiello; Francesco Giuseppe De Rosa; Domenico Aloj; Marco Siccardi; Antonio Biasibetti; Alessandro Massè; Giovanni Di Perri
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

6.  Outcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations.

Authors:  E Fiaux; M Titecat; O Robineau; J Lora-Tamayo; Y El Samad; M Etienne; N Frebourg; N Blondiaux; B Brunschweiler; F Dujardin; E Beltrand; C Loiez; V Cattoir; J P Canarelli; C Hulet; M Valette; S Nguyen; F Caron; H Migaud; E Senneville
Journal:  BMC Infect Dis       Date:  2016-10-13       Impact factor: 3.090

7.  Estimation of drug absorption in antibiotic soaked bone grafts.

Authors:  Manish Ramesh Shah; Rukesh R Patel; Randhirsinh V Solanki; Shailendra H Gupta
Journal:  Indian J Orthop       Date:  2016 Nov-Dec       Impact factor: 1.251

Review 8.  Optimal management of diabetic foot osteomyelitis: challenges and solutions.

Authors:  José Luis Lázaro Martínez; Yolanda García Álvarez; Aroa Tardáguila-García; Esther García Morales
Journal:  Diabetes Metab Syndr Obes       Date:  2019-06-21       Impact factor: 3.168

9.  Italian consensus on the therapeutic management of uncomplicated acute hematogenous osteomyelitis in children.

Authors:  Andrzej Krzysztofiak; Elena Chiappini; Elisabetta Venturini; Livia Gargiullo; Marco Roversi; Carlotta Montagnani; Elena Bozzola; Sara Chiurchiu; Davide Vecchio; Elio Castagnola; Paolo Tomà; Gian Maria Rossolini; Renato Maria Toniolo; Susanna Esposito; Marco Cirillo; Fabio Cardinale; Andrea Novelli; Giovanni Beltrami; Claudia Tagliabue; Silvio Boero; Daniele Deriu; Sonia Bianchini; Annalisa Grandin; Samantha Bosis; Martina Ciarcià; Daniele Ciofi; Chiara Tersigni; Barbara Bortone; Giulia Trippella; Giangiacomo Nicolini; Andrea Lo Vecchio; Antonietta Giannattasio; Paola Musso; Elena Serrano; Paola Marchisio; Daniele Donà; Silvia Garazzino; Luca Pierantoni; Teresa Mazzone; Paola Bernaschi; Alessandra Ferrari; Guido Castelli Gattinara; Luisa Galli; Alberto Villani
Journal:  Ital J Pediatr       Date:  2021-08-28       Impact factor: 2.638

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.